Form 4: Becton Dickinson Executive Reports Stock Transactions

An SEC Form 4 filing reveals stock transactions by Becton Dickinson's EVP and Chief People Officer, Shana Carol Neal, including acquisitions and disposals of common stock and derivative securities.

Summary

• Shana Carol Neal, EVP and Chief People Officer at Becton Dickinson, reported several transactions involving the company's common stock and derivative securities.
• These transactions include the acquisition of common stock through the company's deferred compensation plan on November 18, 2022, November 20, 2023, and November 21, 2024.
• Shares were also disposed of on the same dates to cover withholding taxes.
• Additionally, 788 shares of common stock were sold on January 7, 2025, at a price of $235 per share.
• The transactions were made under a Rule 10b5-1 plan adopted on September 6, 2024.
• The reporting person's total holdings of common stock decreased from 16,989 to 16,201 as a result of the transactions.

Sentiment

Score: 5

Explanation: The document is neutral, reporting routine stock transactions by an executive. There is no indication of positive or negative sentiment, it is simply a disclosure of activity.

Negatives

• The sale of 788 shares by the executive could be interpreted as a negative signal by some investors.

Risks

• Executive stock sales can sometimes be perceived negatively by the market, potentially impacting the stock price.
• The use of a 10b5-1 plan indicates a pre-planned sale, but the market may still react to the transaction.

Industry Context

This filing is a routine disclosure of stock transactions by a company executive, which is common in publicly traded companies. It provides transparency into the trading activities of insiders.

Comparison to Industry Standards

• Executive stock transactions are a common occurrence in publicly traded companies, and the reporting of these transactions via SEC Form 4 is standard practice.
• The use of a Rule 10b5-1 trading plan is also a common method for executives to manage their stock sales while avoiding accusations of insider trading.
• Comparable companies such as Medtronic (MDT) and Abbott Laboratories (ABT) also have executives who regularly file Form 4s for similar transactions.

Stakeholder Impact

• The stock sale by the executive could have a minor impact on shareholder sentiment.

Key Dates

Keywords

SEC Form 4, Becton Dickinson, Stock Transactions, Executive Stock, Rule 10b5-1, Deferred Compensation, Insider Trading